Clinical Relevance and Interplay between miRNAs in Influencing Glioblastoma Multiforme Prognosis.
clinical outcome
glioblastoma
miRNA pairs
miRNAs
overall survival
temozolomide
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
02 Feb 2024
02 Feb 2024
Historique:
received:
19
12
2023
revised:
24
01
2024
accepted:
26
01
2024
medline:
9
2
2024
pubmed:
9
2
2024
entrez:
9
2
2024
Statut:
epublish
Résumé
Glioblastoma multiforme (GBM) is usually treated with surgery followed by adjuvant partial radiotherapy combined with temozolomide (TMZ) chemotherapy. Recent studies demonstrated a better survival and good response to TMZ in methylguanine-DNA methyltransferase (
Identifiants
pubmed: 38334668
pii: cells13030276
doi: 10.3390/cells13030276
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fondazione Ticinese contro il Cancro
ID : 2013 announcement